https://www.globaldata.com/newsletter/details/novartis-bags-paediatric-fda-label-expansion-for-lutathera_302438/?newsletterdate=2024-04-25&hubspotcategory=gd-pharma-prospects-daily&utm_source=website&utm_medium=top_navigation&utm_content=other_daily_news_articles&utm_campaign=type2_pharma
@Phaedrus
An example of label expansion by from our buddies at Novartis
Question- we have run adult trials with a less potent product- could that data along with EAP real world evidence contribute to an expansion into adults?
Reg
https://www.globaldata.com/newsletter/details/novartis-bags-paedi...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.020(1.87%) |
Mkt cap ! $1.244B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.11 | $1.07 | $4.338M | 3.980M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 13222 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 61499 | 3 |
View Market Depth
| Last trade - 16.10pm 13/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.09 |
Change
0.020 ( 1.42 %) |
||||
| Open | High | Low | Volume | ||
| $1.08 | $1.11 | $1.07 | 875231 | ||
| Last updated 15.59pm 13/06/2024 ? | |||||
| MSB (ASX) Chart |